Avid Price To Operating Cash Flows Ratio from 2010 to 2024
| CDMO Stock | USD 12.35 0.02 0.16% |
Check Avid Bioservices financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avid Bioservices' main balance sheet or income statement drivers, such as , as well as many indicators such as . Avid financial statements analysis is a perfect complement when working with Avid Bioservices Valuation or Volatility modules.
Avid |
About Avid Bioservices Financial Statements
Avid Bioservices investors utilize fundamental indicators, such as Price To Operating Cash Flows Ratio, to predict how Avid Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California. Avid Bioservices operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 321 people.
Pair Trading with Avid Bioservices
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Avid Bioservices position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avid Bioservices will appreciate offsetting losses from the drop in the long position's value.Moving together with Avid Stock
Moving against Avid Stock
| 0.71 | VERU | Veru Inc Earnings Call This Week | PairCorr |
| 0.6 | EQ | Equillium | PairCorr |
| 0.53 | VALN | Valneva SE ADR | PairCorr |
| 0.5 | VIGL | Vigil Neuroscience | PairCorr |
| 0.47 | DNTH | Dianthus Therapeutics | PairCorr |
The ability to find closely correlated positions to Avid Bioservices could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Avid Bioservices when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Avid Bioservices - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Avid Bioservices to buy it.
The correlation of Avid Bioservices is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Avid Bioservices moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Avid Bioservices moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Avid Bioservices can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Avid Bioservices Correlation against competitors. To learn how to invest in Avid Stock, please use our How to Invest in Avid Bioservices guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avid Bioservices. If investors know Avid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avid Bioservices listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Avid Bioservices is measured differently than its book value, which is the value of Avid that is recorded on the company's balance sheet. Investors also form their own opinion of Avid Bioservices' value that differs from its market value or its book value, called intrinsic value, which is Avid Bioservices' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avid Bioservices' market value can be influenced by many factors that don't directly affect Avid Bioservices' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avid Bioservices' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avid Bioservices is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avid Bioservices' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.